Rasagiline and Solriamfetol interaction

Rasagiline and Solriamfetol: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Rasagiline label · effective 2020-06-30

Major

Concomitant use of rasagiline with one of many classes of antidepressants (e.g., SSRIs, SNRIs, triazolopyridine, tricyclic or tetracyclic antidepressants) is not recommended [see Drug Interactions ( 7.5 )].

Warnings and precautionsby drug classView label on DailyMed
Major

Antidepressants Concomitant use of rasagiline with one of many classes of antidepressants (e.g., SSRIs, SNRIs, triazolopyridine, tricyclic, or tetracyclic antidepressants) is not recommended [see Warnings and Precautions ( 5.2 ) and Clinical Pharmacology ( 12.3 )] .

Drug interactionsby drug classView label on DailyMed
Moderate

Hypertensive crisis has been reported in patients taking the recommended dose of rasagiline and sympathomimetic medications.

Drug interactionsby drug classView label on DailyMed
Moderate

Severe hypertension has been reported in patients taking the recommended dose of rasagiline and ophthalmic drops containing sympathomimetic medications.

Drug interactionsby drug classView label on DailyMed
Moderate

Nevertheless, caution should be exercised when concomitantly using recommended doses of rasagiline with any sympathomimetic medications including nasal, oral, and ophthalmic decongestants and cold remedies.

Drug interactionsby drug classView label on DailyMed

From the Solriamfetol (SUNOSI) label · effective 2026-05-05

Major

SUNOSI is contraindicated in patients receiving concomitant treatment with monoamine oxidase (MAO) inhibitors, or within 14 days following discontinuation of monoamine oxidase inhibitor, because of the risk of hypertensive reaction [see Drug Interactions ( 7.1 )] .

Contraindicationsby drug classView label on DailyMed
Major

Concurrent treatment with a monoamine oxidase inhibitor (MAOI) or use of an MAOI within the preceding 14 days.

Contraindicationsby drug classView label on DailyMed
Major

Monoamine Oxidase (MAO) Inhibitors Do not administer SUNOSI concomitantly with MAOIs or within 14 days after discontinuing MAOI treatment.

Drug interactionsby drug classView label on DailyMed
Moderate

Concomitant use of MAO inhibitors and noradrenergic drugs may increase the risk of a hypertensive reaction.

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.